A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy of Omalizumab in Prevention of Bronchoconstriction Following Environmental Aeroallergen Exposure

被引：1

作者：

Corren, J. ^{[1
]}

Wood, R. A. ^{[2
]}

Patel, D. ^{[3
]}

Zhu, J. ^{[4
]}

Fish, J. E. ^{[5
]}

机构：

[1] Allergy Res Fdn, Allergy Med Clin, Los Angeles, CA USA

[2] Johns Hopkins Univ, Sch Med, Baltimore, MD USA

[3] Cetero Res, Mississauga, ON, Canada

[4] Genentech Inc, San Francisco, CA 94080 USA

[5] Thomas Jefferson Univ, Gladwyne, PA USA

来源：

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2010年 / 125卷 / 02期

关键词：

D O I：

10.1016/j.jaci.2009.12.282

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：AB72 / AB72

页数：1

共 50 条

[31] Efficacy and Safety of Dichlorphenamide for the Treatment of Periodic Paralysis: a Phase 3 Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Trial
Burge, James
Sansone, Valeria
McDermott, Michael
Smith, Patty
Herr, Barbara
Tawil, Alrabi
Pandya, Shree
Kissel, John
Ciafaloni, Emma
Shieh, Perry
Ralph, Jeffrey
Amato, Anthony
Cannon, Stephen
Trivedi, Jaya
Barohn, Richard
Crum, Brian
Mitsumoto, Hiroshi
Pestronk, Alan
Meola, Giovanni
Conwit, Robin
Jasek, Mark
Hanna, Michael
Griggs, Robert
NEUROLOGY, 2016, 86
[32] Efficacy of andrographolide in not active progressive multiple sclerosis: a prospective exploratory double-blind, parallel-group, randomized, placebo-controlled trial
Ciampi, Ethel
Uribe-San-Martin, Reinaldo
Carcamo, Claudia
Cruz, Juan Pablo
Reyes, Ana
Reyes, Diego
Pinto, Carmen
Vasquez, Macarena
Burgos, Rafael A.
Hancke, Juan
BMC NEUROLOGY, 2020, 20 (01)
[33] Phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel-group study of ustekinumab in patients with Takayasu arteritis
Yoshifuji, Hajime
Ishii, Tomonori
Ohashi, Hiroki
Yoshizawa, Katsunori
Mihoya, Maki
Nishikawa, Kazuko
Nakaoka, Yoshikazu
RHEUMATOLOGY ADVANCES IN PRACTICE, 2025, 9 (02)
[34] A double-blind, randomized, placebo-controlled, parallel-group study of Sativex, in subjects with symptoms of spasticity due to multiple sclerosis
Collin, C.
Ehler, E.
Waberzinek, G.
Alsindi, Z.
Davies, P.
Powell, K.
Notcutt, W.
O'Leary, C.
Ratcliffe, S.
Novakova, I.
Zapletalova, O.
Pikova, J.
Ambler, Z.
NEUROLOGICAL RESEARCH, 2010, 32 (05) : 451 - 459
[35] The efficacy and safety of lixivaptan in outpatients with heart failure and volume overload: results of a multicentre, randomized, double-blind, placebo-controlled, parallel-group study
Ghali, Jalal K.
Orlandi, Cesare
Abraham, William T.
EUROPEAN JOURNAL OF HEART FAILURE, 2012, 14 (06) : 642 - 651
[36] Efficacy and safety of GQ-lab daily in patients with irritable bowel syndrome: A randomized, double-blind, placebo-controlled, parallel-group study
Shin, C. M.
Choi, Y. J.
Yoon, H.
Park, Y. S.
Kim, N.
Lee, D. H.
NEUROGASTROENTEROLOGY AND MOTILITY, 2019, 31
[37] Randomized, double-blind, placebo-controlled, parallel-group, multi-center study of the safety and efficacy of ADAM zolmitriptan for the acute treatment of migraine
Spierings, Egilius L. H.
Brandes, Jan Lewis
Kudrow, David B.
Weintraub, James
Schmidt, Peter C.
Kellerman, Donald J.
Tepper, Stewart J.
CEPHALALGIA, 2018, 38 (02) : 215 - 224
[38] The reduction impact of monoglucosyl rutin on abdominal visceral fat: A randomized, placebo-controlled, double-blind, parallel-group
Hashizume, Yushi
Tandia, Mahamadou
JOURNAL OF FOOD SCIENCE, 2020, 85 (10) : 3577 - 3589
[39] A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Trial of Extract Sceletium tortuosum (Zembrin) in Healthy Adults
Nell, Haylene
Siebert, Mirna
Chellan, Pashini
Gericke, Nigel
JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE, 2013, 19 (11) : 898 - 904
[40] A DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED STUDY OF LACTULOSE IN THE TREATMENT OF ENCOPRESIS IN CHILDREN WITH CHRONIC CONSTIPATION
GLEASON, W
FIGUEROACOLON, R
ROBINSON, LH
BROWDERHUGHES, S
PHILLIPS, R
FLEISHMAN, C
FRANK, D
NESTER, T
GASTROENTEROLOGY, 1995, 108 (04) : A606 - A606

← 1 2 3 4 5 →